Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes From the STORM-PE Trial
Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes From the STORM-PE Trial
Khanjan Nagarsheth, Zachary Rosol, Grzegorz Kopeć, Ido Weinberg et al.
Citations
10 citations
Journal
Circulation
Topics
Venous Thromboembolism Diagnosis and Management
Field-Weighted Citation Impact (FWCI)
18.70
article
Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes From the STORM-PE Trial
Khanjan Nagarsheth, Zachary Rosol, Grzegorz Kopeć, Ido Weinberg, Sahil A. Parikh, Stavros Konstantinides, R. Lookstein, Braedon McDonald, Richard N. Channick, Andrew Holden, Rachel Rosovsky, John M. Moriarty, Kei Yamada, Suhail Dohad
article en
10 citations
Abstract
No abstract available for this paper.
Publication Tag
CirculationVol. 153(1)
Institutions
Jagiellonian University (PL), Harvard University (US), Democritus University of Thrace (GR), University of California, Los Angeles (US), University of Calgary (CA), Johannes Gutenberg University Mainz (DE), Columbia University Irving Medical Center (US), Auckland City Hospital (NZ), Baylor University Medical Center (US), Massachusetts General Hospital (US), University Medical Center of the Johannes Gutenberg University Mainz (DE), John Paul II Hospital (PL), Cedars-Sinai Smidt Heart Institute (US), Center for Vascular Biology Research (US), Baylor Jack and Jane Hamilton Heart and Vascular Hospital (US), Pulmonary and Critical Care Associates (US), Mass General Brigham (US), University of Maryland, College Park (US), Icahn School of Medicine at Mount Sinai (US)